Cytologic, clinicopathologic, and molecular features of papillary thyroid carcinoma with prominent hobnail features: 10 case reports and systematic literature review

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 7, 2015, Pages 7988-7997

  Lee, Young Sub ^a   Kim, Yourha ^a   Jeon, Sora ^a   Bae, Ja Seong ^a   Jung, So Lyung ^a   Jung, Chan Kwon ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

ALK; BRAF; Fine needle aspiration; Hobnail variant; TERT; Thyroid cancer

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; B RAF KINASE; BRAF PROTEIN, HUMAN; PROTEIN TYROSINE KINASE; TELOMERASE; TERT PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; BIOPSY; CANCER STAGING; CARCINOMA; CASE REPORT; CHEMISTRY; DISEASE FREE SURVIVAL; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; PATHOLOGY; PHENOTYPE; PROMOTER REGION; RETROSPECTIVE STUDY; SURVIVAL ANALYSIS; THYROID NEOPLASMS; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; BIOPSY; CARCINOMA; DISEASE-FREE SURVIVAL; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; NEOPLASM STAGING; PHENOTYPE; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS B-RAF; RECEPTOR PROTEIN-TYROSINE KINASES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TELOMERASE; THYROID NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84995426988     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Roman S and Sosa JA. Aggressive variants of papillary thyroid cancer. Curr Opin Oncol 2013; 25: 33-38.
2. Albores-Saavedra J. Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of 8 cases. Am J Surg Pathol 2010; 34: 913; author reply 914.
3. Asioli S, Erickson LA, Righi A and Lloyd RV. Papillary thyroid carcinoma with hobnail features: histopathologic criteria to predict aggressive behavior. Hum Pathol 2013; 44: 320-328.
4. Asioli S, Erickson LA, Sebo TJ, Zhang J, Jin L, Thompson GB and Lloyd RV. Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical and molecular study of eight cases. Am J Surg Pathol 2010; 34: 44-52.
5. Asioli S, Maletta F, Pagni F, Pacchioni D, Vanzati A, Mariani S, Palestini N, Lloyd RV and Sapino A. Cytomorphologic and molecular features of hobnail variant of papillary thyroid carcinoma: case series and literature review. Diagn Cytopathol 2014; 42: 78-84.
6. Motosugi U, Murata S, Nagata K, Yasuda M and Shimizu M. Thyroid papillary carcinoma with micropapillary and hobnail growth pattern: a histological variant with intermediate malignancy? Thyroid 2009; 19: 535-537.
7. Elisei R, Viola D, Torregrossa L, Giannini R, Romei C, Ugolini C, Molinaro E, Agate L, Biagini A, Lupi C, Valerio L, Materazzi G, Miccoli P, Piaggi P, Pinchera A, Vitti P and Basolo F. The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study. J Clin Endocrinol Metab 2012; 97: 4390-4398.
8. Xing M, Alzahrani AS, Carson KA, Viola D, Elisei R, Bendlova B, Yip L, Mian C, Vianello F, Tuttle RM, Robenshtok E, Fagin JA, Puxeddu E, Fugazzola L, Czarniecka A, Jarzab B, O'Neill CJ, Sywak MS, Lam AK, Riesco-Eizaguirre G, Santisteban P, Nakayama H, Tufano RP, Pai SI, Zeiger MA, Westra WH, Clark DP, Clifton-Bligh R, Sidransky D, Ladenson PW and Sykorova V. Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. JAMA 2013; 309: 1493-1501.
9. Xing M, Alzahrani AS, Carson KA, Shong YK, Kim TY, Viola D, Elisei R, Bendlova B, Yip L, Mian C, Vianello F, Tuttle RM, Robenshtok E, Fagin JA, Puxeddu E, Fugazzola L, Czarniecka A, Jarzab B, O'Neill CJ, Sywak MS, Lam AK, Riesco-Eizaguirre G, Santisteban P, Nakayama H, Clifton-Bligh R, Tallini G, Holt EH and Sykorova V. Association between BRAF V600E mutation and recurrence of papillary thyroid cancer. J Clin Oncol 2015; 33: 42-50.
10. Amacher AM, Goyal B, Lewis JS Jr, El-Mofty SK and Chernock RD. Prevalence of a Hobnail Pattern in Papillary, Poorly Differentiated, and Anaplastic Thyroid Carcinoma: A Possible Manifestation of High-grade Transformation. Am J Surg Pathol 2015; 39: 260-265.
11. Lubitz CC, Economopoulos KP, Pawlak AC, Lynch K, Dias-Santagata D, Faquin WC and Sadow PM. Hobnail variant of papillary thyroid carcinoma: an institutional case series and molecular profile. Thyroid 2014; 24: 958-965.
12. Liu X, Bishop J, Shan Y, Pai S, Liu D, Murugan AK, Sun H, El-Naggar AK and Xing M. Highly prevalent TERT promoter mutations in aggressive thyroid cancers. Endocr Relat Cancer 2013; 20: 603-610.
13. Liu X, Qu S, Liu R, Sheng C, Shi X, Zhu G, Murugan AK, Guan H, Yu H, Wang Y, Sun H, Shan Z, Teng W and Xing M. TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer. J Clin Endocrinol Metab 2014; 99: E1130-1136.
14. Lastra RR, LiVolsi VA and Baloch ZW. Aggressive variants of follicular cell-derived thyroid carcinomas: a cytopathologist's perspective. Cancer Cytopathol 2014; 122: 484-503.
15. Cibas ES, Ali SZ and Conference NCITFSotS. The Bethesda System For Reporting Thyroid Cytopathology. Am J Clin Pathol 2009; 132: 658-665.
16. Cho U, Oh WJ, Bae JS, Lee S, Lee YS, Park GS, Lee YS and Jung CK. Clinicopathological features of rare BRAF mutations in Korean thyroid cancer patients. J Korean Med Sci 2014; 29: 1054-1060.
17. Park G, Kim TH, Lee HO, Lim JA, Won JK, Min HS, Lee KE, Park do J, Park YJ and Park WY. Standard immunohistochemistry efficiently screens for anaplastic lymphoma kinase rearrangements in differentiated thyroid cancer. Endocr Relat Cancer 2015; 22: 55-63.
18. Amacher AM, Goyal B, Lewis JS Jr, El-Mofty SK and Chernock RD. Prevalence of a hobnail pattern in papillary, poorly differentiated, and anaplastic thyroid carcinoma: a possible manifestation of high-grade transformation. Am J Surg Pathol 2015; 39: 260-265.
19. Bellevicine C, Cozzolino I, Malapelle U, Zeppa P and Troncone G. Cytological and molecular features of papillary thyroid carcinoma with prominent hobnail features: a case report. Acta Cytol 2012; 56: 560-564.
20. Yang GC, Fried K and Scognamiglio T. Cytological features of clear cell thyroid tumors, including a papillary thyroid carcinoma with prominent hobnail features. Diagn Cytopathol 2013; 41: 757-761.
21. Lee SH, Jung CK, Bae JS, Jung SL, Choi YJ and Kang CS. Liquid-based cytology improves preoperative diagnostic accuracy of the tall cell variant of papillary thyroid carcinoma. Diagn Cytopathol 2014; 42: 11-17.
22. Parameswaran R, Brooks S and Sadler GP. Molecular pathogenesis of follicular cell derived thyroid cancers. Int J Surg 2010; 8: 186-193.
23. Oh WJ, Lee YS, Cho U, Bae JS, Lee S, Kim MH, Lim DJ, Park GS, Lee YS and Jung CK. Classic papillary thyroid carcinoma with tall cell features and tall cell variant have similar clinicopathologic features. Korean J Pathol 2014; 48: 201-208.
24. Kelly LM, Barila G, Liu P, Evdokimova VN, Trivedi S, Panebianco F, Gandhi M, Carty SE, Hodak SP, Luo J, Dacic S, Yu YP, Nikiforova MN, Ferris RL, Altschuler DL and Nikiforov YE. Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer. Proc Natl Acad Sci U S A 2014; 111: 4233-4238.